Don't overlook the short term facts.. the cannabis sector has bottomed out again after the Trump rally on 4/13 caused by good news for the sector. The overall cannabis sector historically has had significant influence on OWC's share price, I believe much more significantly than any other factor including the Friedland BS and recent 10k.
So to sum up everything for the short term:
1) Right now we have a bottomed out sector with consistent low volume. When volume comes back, the sector will move up and so will OWCP simply because of volume.
2) W$5,000,000 institutional investor (Big pharma?). We now have new possibilities and are likely to hear about moves the company is making very soon, I'm sure Hirsche already has plans beforehand about how much $ they need and for what. The PR regarding this gives insight as to their intentions, one of which is getting products out there. Also if you don't know this, OTC stocks like to move on anticipation of something great to come soon, before it happens, not after. "Buy the rumor, sell the news" is a general rule of thumb that many traders and investors use. Yes, we had news, but this particular news is going to create "rumors", or anticipation. Then the hype comes later where we really take off. For those of you who are familiar with Clay Trader, that's when he will show up, after the initial run up with high volume.
3) Low share price. I don't have to go into this but I will in OWC's case because every time the share price has reached new lows, not long after we have seen massive gains of 50-80% over 2-5 days time. The next big rally can easily be over 100% due to the low low share price. I was hoping to see this break below .20 and get another rally caused solely by a new low, but unfortunately didn't happen. But doesn't matter, we are still only 25% higher than the 1-year low of .20, which we have bounced off 3/3 times, once last year and two times recently you can call a double bounce when looking at a 1 or 2 year chart.
4) Safety trial results for the psoriasis cream. After the wall street conference in February, the price soared (out of anticipation). Then not only was no news announced, but also we found out the safety trial results were delayed again to Q2. Well, we are in the last month of Q2. Another delay to Q3? Probably, but most people are expecting it this month, so we should have more buyers than sellers that are executing orders based on the trial results.
5) A number of other long term catalysts, many things in play that we do and don't know about, all of which will contribute to having more buyers than sellers in the long term and help to retain PPS gains.
x100xPercent
